永和流体智控股份有限公司 关于公开挂牌转让昆明医科肿瘤医院有限公司100%股权的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 11 月 18 日召开第五 届董事会第二十六次临时会议、第五届监事会第二十次临时会议，审议通过了《关于 拟公开挂牌转让昆明医科肿瘤医院有限公司 100%股权的议案》，同意公司在产权交 易所公开挂牌转让全资孙公司昆明医科肿瘤医院有限公司（以下简称"昆明医科"） 100%股权，并同意授权公司董事长或董事长授权的代理人负责具体实施该事项。具 体内容详见公司于 2025 年 11 月 19 日在巨潮资讯网（http://www.cninfo.com.cn）、 《证券时报》和《证券日报》刊登的《关于拟公开挂牌转让昆明医科肿瘤医院有限公 司 100%股权的公告》（公告编号：2025-062）。 证券代码：002795 证券简称：永和智控 公告编号：2025-080 鉴于前两次公开挂牌公告期内未能征集到符合条件的意向受让方，公司继续推进 公开挂牌转让昆明医科 1 ...

永和流体智控股份有限公司 关于公开挂牌转让普乐新能源科技（泰兴）有限公司51%股权 证券代码：002795 证券简称：永和智控 公告编号：2025-081 及债权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 鉴于首次公开挂牌公示期内未能征集到符合条件的意向受让方，公司持续推进第 二次挂牌转让，挂牌转让底价为 2,439.20 万元，挂牌公示期为 2025 年 11 月 20 日起 至 2025 年 11 月 26 日止。截止 2025 年 11 月 26 日 17:00 公告期满，无意向受让方报 名参与投资。具体内容详见公司于 2025 年 11 月 21 日、2025 年 11 月 29 日在巨潮资 讯网（http://www.cninfo.com.cn）、《证券时报》和《证券日报》刊登的《关于公开 挂牌转让普乐新能源科技（泰兴）有限公司 51%股权及债权的进展公告》（公告编 号：2025-065）、《关于公开挂牌转让普乐新能源科技（泰兴）有限公司 51%股权及 债权的进展公告》（公告编号：2025-068）。 为继续推进公开挂牌转让泰兴普乐 ...

Group 1 - The BC Battery Index experienced a decline, with constituent stocks showing a widespread downward trend [1] - Dike Co., Ltd. saw a decrease of 6.17%, while Guangxin Materials dropped by 3.35% [1] - Yonghe Intelligent Control fell by 3.23%, Zhonglai Co., Ltd. decreased by 1.86%, and Shichuang Energy declined by 1.76% [1]

证券代码：002795 证券简称：永和智控 公告编号：2025-079 一、担保情况概述 永和流体智控股份有限公司（以下简称"公司"）为满足公司经营发展需要， 向华夏银行股份有限公司台州玉环支行借款 7,000 万元流动资金。近日，公司收 到了公司全资子公司浙江永和智控科技有限公司（以下简称"永和科技"）与华夏 银行股份有限公司台州玉环支行签署的《最高额保证合同》，永和科技在最高债 权额限度内为公司与华夏银行股份有限公司台州玉环支行连续发生的多笔债务 提供保证担保，被担保的最高债权额为 7,000 万元。 根据《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监 管指引第 1 号——主板上市公司规范运作》、《公司章程》等相关规定，本次担 保事项无需提交公司董事会、股东会审议。 二、被担保人基本情况 公司名称：永和流体智控股份有限公司 注册地址：浙江省台州市玉环市清港镇工业产业集聚区 法定代表人：魏璞 注册资本：44,580.6998 万人民币 永和流体智控股份有限公司 关于全资子公司为公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ...

12月9日，永和智控（002795）发布公告，关于公开挂牌转让公司全资孙公司昆明医科肿瘤医院有限公司100%股权的进展情况。 为继续推进转让事项，公司将第四次挂牌底价下调60%至1220万元，公示期为2025年12月9日至2025年12月15日。 近年来，永和智控业绩承压，2022年~2024年分别净亏损2618.67万元、1.56亿元、2.97亿元。今年以来永和智控频繁挂牌转让子公司，或是为了"割肉求 生"。 最新业绩显示，2025年前三季度，永和智控实现营业收入为5.82亿元，同比下降7.2%；归母净利润自去年同期亏损7620万元变为亏损6046万元，亏损额有 所减少；扣非归母净利润自去年同期亏损7591万元变为亏损5294万元，亏损额有所减少；经营现金流净额为4789万元，同比增长162.6%；EPS(全面摊薄) 为-0.1356元。 其中第三季度，公司营业收入为2.15亿元，同比上升4.3%；归母净利润自去年同期亏损1996万元变为亏损2284万元，亏损额进一步扩大；扣非归母净利润 自去年同期亏损2047万元变为亏损1774万元，亏损额有所减少；EPS为-0.0512元。 ↓↓↓ 公司于2025年11 ...

永和流体智控股份有限公司 关于公开挂牌转让普乐新能源科技（泰兴）有限公司51%股权 及债权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 10 月 10 日、2025 年 10 月 29 日召开第五届董事会第二十二次临时会议、第五届监事会第十七次临时会议 及 2025 年第二次临时股东大会，审议通过了《关于拟公开挂牌转让普乐新能源科技 （泰兴）有限公司 51%股权及债权的议案》，同意公司在产权交易所公开挂牌转让 控股子公司普乐新能源科技（泰兴）有限公司（以下简称"泰兴普乐"）51%股权及公 司对泰兴普乐的全部债权，并同意授权公司董事长或董事长授权的代理人负责具体实 施 该 事 项 。 具 体 内 容 详 见 公 司 于 2025 年 10 月 14 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）、《证券时报》和《证券日报》刊登的《关于拟公开挂 牌转让普乐新能源科技（泰兴）有限公司 51%股权及债权的公告》（公告编号： 2025-041）。 ...

证券代码：002795 证券简称：永和智控 公告编号：2025-077 永和流体智控股份有限公司 1 价格基础上下调 20%进行第二次挂牌，第二次挂牌转让底价为 2,874.216 万元。挂牌 公示期为 2025 年 12 月 9 日起至 2025 年 12 月 15 日止。 三、风险提示 关于公开挂牌转让昆明医科肿瘤医院有限公司100%股权的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 11 月 18 日召开第五 届董事会第二十六次临时会议、第五届监事会第二十次临时会议，审议通过了《关于 拟公开挂牌转让昆明医科肿瘤医院有限公司 100%股权的议案》，同意公司在产权交 易所公开挂牌转让全资孙公司昆明医科肿瘤医院有限公司（以下简称"昆明医科"） 100%股权，并同意授权公司董事长或董事长授权的代理人负责具体实施该事项。具 体内容详见公司于 2025 年 11 月 19 日在巨潮资讯网（http://www.cninfo.com.cn）、 《证券时报》和《证券日报》刊登的《关 ...

Core Insights - Recent announcements from Yonghe Zhikong and Dadongfang reveal significant low-price disposals of their private hospitals, indicating a distress in the healthcare sector [3][8] - Yonghe Zhikong has been unable to attract buyers for its hospitals, with prices dropping drastically, exemplified by a 90% reduction in the valuation of Dazhou Medical Oncology Hospital [6][7] - Dadongfang is also divesting underperforming assets, including a hospital sold for just 1 yuan, reflecting challenges in the healthcare market [8][11] Yonghe Zhikong Overview - Yonghe Zhikong has been attempting to pivot towards the healthcare sector since 2019, acquiring several oncology hospitals to enhance profitability [3][4] - Despite these efforts, the revenue from medical services has remained low, peaking at approximately 148 million yuan in 2023, which constituted about 15.57% of total revenue [4] - The company has faced continuous losses from its hospital operations, with Dazhou Medical Oncology Hospital reporting a net loss of 706,000 yuan in 2024 [6][7] Financial Performance and Asset Disposals - Yonghe Zhikong's attempts to sell its hospitals have seen significant price reductions, with the Dazhou Medical Oncology Hospital's share price dropping from 27.67 million yuan to 2.77 million yuan [5][6] - The company has also listed other hospitals for sale, including the Kunming Medical Oncology Hospital, which is being offered at 33% of its original acquisition price [5][6] - The financial struggles of these hospitals are evident, with all four hospitals listed for sale reporting ongoing losses and one having negative net assets [5][6][7] Dadongfang Overview - Dadongfang has been strategically divesting certain underperforming hospital assets, including the sale of Jin Hua Lian Ji Hospital for 1 yuan [8][11] - The company has expanded its healthcare services through acquisitions since 2022, focusing on pediatric care and other medical services [9][10] - Despite growth in revenue from pediatric services, the overall profitability remains low, with significant fixed costs impacting financial performance [10][11] Market Challenges - Both companies are facing challenges due to changes in healthcare policies and market conditions, leading to declining revenues and increased operational losses [11] - The healthcare sector is experiencing a shift, with companies needing to adapt to new economic realities and consumer demands to remain viable [9][10]

Key Points - Company Grinda plans to invest 80 million yuan to subscribe for 1.91% of Muxi's initial public offering shares [1] - Fuyong Technology clarifies that its products do not possess AI capabilities [1] - Bohui Paper Industry intends to invest 1.7 billion yuan to establish a project with an annual production capacity of 320,000 tons of chemical pulp [1] - Jinggong Technology has won the bid for the Wuhan Qingshan high-performance carbon fiber production base project [1] - Yonghe Intelligent Control plans to transfer 100% equity and debt of its wholly-owned subsidiary Chengdu Shanshui [2] - Zhigang Home plans to repurchase shares with an investment of 80 million to 110 million yuan [2] - Meikailong's shareholder Hangzhou Haoyue intends to reduce its holdings by no more than 131 million shares [2] - International Medical plans to raise no more than 1.008 billion yuan through a private placement [2] - Guizhou Bailin's actual controller Jiang Wei has received a notice of investigation from the Securities Regulatory Commission [2]

Group 1 - Yonghe Intelligent Control plans to publicly transfer 100% equity and a debt of 114 million yuan of its subsidiary Chengdu Shanshuishang Hotel, with a minimum listing price of 185 million yuan [1] - Grinda intends to invest 79.9999 million yuan to subscribe for 764,400 shares of Muxi Integrated Circuit (Shanghai) Co., accounting for 0.19% of the total share capital after issuance [1] - Tianshan Aluminum's actual controllers plan to reduce their holdings by no more than 1% of the company's shares starting from December 25, 2025 [1][2] Group 2 - Guang'an Aizhong plans to publicly issue bonds not exceeding 1 billion yuan to repay debts and supplement working capital [3] - Tengda Technology's shareholder plans to reduce holdings by no more than 0.8% of the company's shares starting from December 26, 2025 [4] - Tianwo Technology intends to invest in a 300,000-kilowatt "solar thermal + wind power integration" project with a total investment not exceeding 1.918 billion yuan [5][6] Group 3 - Yunnan Energy Investment announces that three wind power expansion projects have achieved full capacity grid connection, adding 596,250 kilowatts of wind power capacity [7] - Jinggong Technology wins a bid for a carbon fiber production base project worth 729 million yuan, accounting for 42.16% of its audited revenue for 2024 [8] - CITIC Bank's risk director's qualification has been approved by the regulatory authority [9][10] Group 4 - Electric Media plans to establish a joint venture with Mango Super Media and Zhangjiajie Tourism Group with a registered capital of 180 million yuan [11] - New Lai Ying Material's subsidiary plans to invest 157 million yuan to acquire a 51% stake in Anpu Intelligent Technology [13] - Kuaiji Elevator has been notified of the cancellation of its high-tech enterprise qualification for 2021-2023, which may impact its operating performance [15] Group 5 - Huakai Yibai's shareholders plan to reduce their holdings by no more than 2.94% of the company's shares [16] - Del Shares' shareholder plans to reduce holdings by no more than 2.98% of the company's shares [17] - Rifa Precision plans to sell idle assets for 155 million yuan to an affiliated party [19] Group 6 - Wanlong Optoelectronics is planning a major asset restructuring and has suspended trading of its shares [20] - Bangjie Co.'s shareholder plans to reduce holdings by no more than 400,000 shares [22] - Nanhua Instrument's actual controller and related parties plan to reduce holdings by no more than 1.62% of the company's shares [24] Group 7 - Unisplendour has re-submitted its H-share listing application to the Hong Kong Stock Exchange [25] - Zhongshi Technology plans to acquire 51% of Zhongshi Xun Cold for 35.7 million yuan [26] - Pulutong is planning a major asset restructuring and has suspended trading of its shares [26]